Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
A phase I trial in patients with relapsed or refractory leukemia of a human monoclonal
antibody that kills B cell acute lymphoblastic leukemia. Trial will study safety,
pharmacokinetics, and anti tumor activity of the antibody given as a single agent and with
vincristine.